Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of single-dose nolasiban to improve pregnancy outcomes after fresh embryo transfer in IVF or ICSI
2016-004266-25Phase 3Completed
- Sponsor
- ObsEva SA
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in female infertility comparing Nolasiban with Placebo (2 arms). Primary endpoint: Ongoing clinical pregnancy rate. Started Dec 2016; status: completed.
02
Drugs
nolasiban
03
Conditions
female infertility
Beyond the preview
Go deeper on 2016-004266-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004266-25.